EP1236720B1 — Sulfonyl pyridazinone compounds useful as aldose reductase inhibitors
Assigned to Pfizer Products Inc · Expires 2005-06-15 · 21y expired
What this patent protects
Compounds of the formula (I): <CHEM> a prodrug thereof or a pharmaceutically acceptable salt of said compound or said prodrug, wherein R<1>, R<2>, X and Y are as defined in the claims are aldose reductase inhibitors useful in the treatment or prevention of diabe…
USPTO Abstract
Compounds of the formula (I): <CHEM> a prodrug thereof or a pharmaceutically acceptable salt of said compound or said prodrug, wherein R<1>, R<2>, X and Y are as defined in the claims are aldose reductase inhibitors useful in the treatment or prevention of diabetic complications.
Drugs covered by this patent
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.